control group:bismuth-based quadruple therapy

2 trials

Sponsors

Peking University First Hospital, Changzhou Second People's Hospital

Conditions

Helicobacter pyloriHelicobacter pylori infection

Phase 4

Comparison of efficacy and safety between high-dose amoxicillin-vonoprazan dual therapy and bismuth-based quadruple therapy for Helicobacter pylori eradication

RecruitingChiCTR2100052550

Peking University First HospitalHelicobacter pylori infection

Start: 2021-12-01Updated: 2022-10-17

Clinical study of dual combination therapy of vonola fumarate and amoxicillin in the treatment of Helicobacter pylori infection

RecruitingChiCTR2100055101

Changzhou Second People's HospitalHelicobacter pylori

Start: 2022-01-15Updated: 2023-01-09

Related Papers

Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori

BMC Gastroenterology2024-11-262 citations

Efficacy and safety of vonoprazan–amoxicillin dual therapy for <i>Helicobacter pylori</i> first-line treatment: a single-center, randomized, controlled trial

Therapeutic Advances in Gastroenterology2023-01-0124 citations